Cellectis (CLLS) Says Two Issued US Patents Granted for CRISPR Use in T-Cells
Source: Cellectis (CLLS) Says Two Issued US Patents Granted for CRISPR Use in T-Cells
[unable to retrieve full-text content]
|
Published at Tue, 13 Feb 2018 11:36:00 +0000
Leave a Reply
You must be logged in to post a comment.